• OPEN AN ACCOUNT
Indian Indices
Nifty
25,910.05 30.90
(0.12%)
Sensex
84,562.78 84.11
( 0.10%)
Bank Nifty
58,517.55 135.60
( 0.23%)
Nifty IT
36,301.25 -378.20
( -1.03%)
Global Indices
Nasdaq
47,163.83 -314.39
(-0.66%)
Dow Jones
6,754.35 -4.14
(-0.06%)
Hang Seng
50,333.56 -948.27
(-1.85%)
Nikkei 225
9,693.83 -113.85
(-1.16%)
Forex
USD-INR
88.71 0.12
(0.13%)
EUR-INR
103.04 0.44
(0.43%)
GBP-INR
116.72 0.41
(0.35%)
JPY-INR
0.57 0.00
(0.16%)

EQUITY - MARKET SCREENER

Andrew Yule & Company Ltd
Industry :  Diversified - Medium / Small
BSE Code
ISIN Demat
Book Value()
526173
INE449C01025
2.070367
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ANDREWYU
120.9
1241.45
EPS(TTM)
Face Value()
Div & Yield %
0.21
2
0
 

foseco crucible (india) ltd
Board of Sanofi India approves change in directorate
Oct 27,2025
The Board of Sanofi India at its meeting held on 27 October 2025 has approved the following-

Appointment of Deepak Arora (DIN: 07495638) as an Additional Director of the Company with effect from 27 October 2025 and as a Managing Director (Key Managerial Personnel) of the Company for a term of 3 (three) years effective from 27 October 2025.

Stepping down of Rachid Ayari as Interim Managing Director of the Company with effect from close of 26 October 2025. However, Rachid Ayari would continue to serve the Company in his role as Whole time Director and Chief Financial Officer of the Company.